Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics

Published:2022-06-16 Issue:1 Volume:14 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Geddie Melissa L.¹²,Kirpotin Dmitri B.¹³,Kohli Neeraj¹⁴,Kornaga Tad¹,Boll Bjoern¹⁵,Razlog Maja¹⁶,Drummond Daryl C.¹³,Lugovskoy Alexey A.¹²

Affiliation:

1. Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA

2. Research & Development, Diagonal Therapeutics, Cambridge, Massachusetts, USA

3. Research & Development, Akagera Medicines, San Francisco, CA, USA

4. Janssen Research & Development, Spring House, Pennsylvania, USA

5. Drug Product Design, ten23 Health, Basel, Switzerland

6. Research, Verseau Therapeutics, Bedford, Massachusetts, USA

Funder

article

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2022.2083466

Reference43 articles.

1. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

2. Development of ligand-targeted liposomes for cancer therapy

3. The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment

4. Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells

5. Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of mRNA technologies and delivery systems for new modality therapeutics;Journal of Biomedical Science;2024-09-10

2. Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook;Molecular Pharmaceutics;2023-12-20

3. The clinical progress and challenges of mRNA vaccines;WIREs Nanomedicine and Nanobiotechnology;2023-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3